81
Pharma & HealthcareStrong Buy
HDFC Pharma And Healthcare
HDFC · Direct–Growth · rank #2 of 19 by Smart Score
Data updated
Trailing returns
1 Year
27.3%
+29.4% vs index
3 Years
—
5 Years
—
Since launch
32.3%
Year-by-year performance
2024
+52.2%+36.6% vs index
2025
+2.4%-5.3% vs index
2026
+28.8%+32.4% vs index
Why this score
HDFC Pharma And Healthcare scores 81/100 — #2 of 19 Pharma & Healthcare fund (Strong Buy). It stands out for sharpe ratio and alpha — beating 97% of peers on sharpe ratio. It has no major weak spot vs the category.
Each bar shows the fund's percentile vs Pharma & Healthcare peers — a longer bar beats more of the category.
Sharpe ratio1.84 · 97th percentile in category
Alpha21.88 · 97th percentile in category
Sortino ratio2.64 · 97th percentile in category
1Y return27.29% · 97th percentile in category
Fund size3310.64 Cr · 71st percentile in category
Volatility14.02 · 66th percentile in category
Top holdings
1.Divi's Laboratories Ltd9.54%
2.Sun Pharmaceutical Industries Ltd8.94%
3.Torrent Pharmaceuticals Ltd4.08%
4.Max Healthcare Institute Ltd4.06%
5.Lupin Ltd4.04%
39 disclosed equity positions · portfolio as of Aug 2026 · weights are % of total corpus.